Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023
“The global clinical microbiology market is projected to grow at a CAGR of 6.4% in the next five years”
The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.
“The reagents segment is projected to grow at the highest CAGR during the forecast period.”
By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.
“Asia Pacific to witness the highest growth during the forecast period (2018-2023)”
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.
Break-up of primary participants was as mentioned below:
Some of the major market players in the microbiology testing/clinical microbiology market are bioM?rieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.
Research Coverage:
This report studies the microbiology testing market based on applications and region and the clinical microbiology market based on product, disease area, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and trends) which affect market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for key players. The microbiology testing/clinical microbiology market report profiles key players who are involved in the manufacturing and commercialization of microbiology testing products and analyzes their core competencies. The report also tracks and analyzes competitive developments in the market such as product launches and enhancements; acquisitions; partnerships and collaborations; and expansions.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help players capture larger market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies to strengthen their position in the market:
The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.
“The reagents segment is projected to grow at the highest CAGR during the forecast period.”
By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.
“Asia Pacific to witness the highest growth during the forecast period (2018-2023)”
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.
Break-up of primary participants was as mentioned below:
- By Company Type – Tier 1–33%, Tier 2–46% and Tier 3–21%
- By Designation – C-level–26%, Director Level–20%, Others–54%
- By Region – North America–33%, Europe–29%, Asia Pacific–24%, RoW–14%
Some of the major market players in the microbiology testing/clinical microbiology market are bioM?rieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.
Research Coverage:
This report studies the microbiology testing market based on applications and region and the clinical microbiology market based on product, disease area, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and trends) which affect market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for key players. The microbiology testing/clinical microbiology market report profiles key players who are involved in the manufacturing and commercialization of microbiology testing products and analyzes their core competencies. The report also tracks and analyzes competitive developments in the market such as product launches and enhancements; acquisitions; partnerships and collaborations; and expansions.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help players capture larger market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies to strengthen their position in the market:
- Market Penetration: Comprehensive information on the top 15 players in the microbiology testing/clinical microbiology market. The report analyzes the microbiology testing market by application and region; and the clinical microbiology market by product, disease area, end user, and region
- Product Development/Innovation: Detailed insights on research and development activities and new product launches in the microbiology testing/clinical microbiology market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various microbiology testing products across five geographies (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa)
- Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the clinical microbiology market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY AND PRICING
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 OPPORTUNITY INDICATORS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Burden of infectious diseases
2.2.2.2 Healthcare expenditure patterns
2.2.2.3 Rapid growth in geriatric population
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 The number of new products launched as clinical microbiology products
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH LIMITATIONS AND ASSUMPTIONS
2.5.1 LIMITATIONS
2.5.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MICROBIOLOGY TESTING MARKET (2018-2023)
4.2 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018-2023 (USD BILLION)
4.3 CLINICAL MICROBIOLOGY MARKET (2018-2023)
4.4 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
4.5 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2018 VS. 2023 (USD MILLION)
4.6 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in disease diagnostics
5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics
5.2.1.3 Increased funding and public-private investments
5.2.2 RESTRAINTS
5.2.2.1 Limited reimbursement policies for microbiology testing procedures
5.2.2.2 Unfavorable regulatory scenario
5.2.3 OPPORTUNITIES
5.2.3.1 Improving healthcare infrastructure across emerging countries
5.2.4 CHALLENGES
5.2.4.1 Operational barriers related to the use of diagnostic tests
5.2.4.2 Bundled sales of microbiology testing products - A key challenge for small and emerging reagent manufacturers
6 MICROBIOLOGY TESTING MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 PHARMACEUTICAL APPLICATIONS
6.3 CLINICAL APPLICATIONS
6.4 FOOD TESTING APPLICATIONS
6.5 ENERGY APPLICATIONS
6.6 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS
6.7 ENVIRONMENTAL APPLICATIONS
7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 INSTRUMENTS
7.2.1 LABORATORY INSTRUMENTS
7.2.1.1 Incubators
7.2.1.2 Gram stainers
7.2.1.3 Bacterial colony counters
7.2.1.4 Autoclave sterilizers
7.2.1.5 Microbial air samplers
7.2.1.6 Anaerobic culture systems
7.2.1.7 Petri dish fillers
7.2.1.8 Blood culture systems
7.2.1.9 Microbial culture systems
7.2.1.10 Other laboratory instruments
7.2.2 MICROBIOLOGY ANALYZERS
7.2.2.1 Molecular diagnostic instruments
7.2.2.2 Microscopes
7.2.2.3 Mass spectrometers
7.3 REAGENTS
7.3.1 PATHOGEN-SPECIFIC KITS
7.3.2 GENERAL REAGENTS
8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA
8.1 INTRODUCTION
8.2 RESPIRATORY DISEASES
8.3 BLOODSTREAM INFECTIONS
8.4 GASTROINTESTINAL DISEASES
8.5 SEXUALLY TRANSMITTED DISEASES
8.6 URINARY TRACT INFECTIONS
8.7 PERIODONTAL DISEASES
8.8 OTHER DISEASES
9 CLINICAL MICROBIOLOGY MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & DIAGNOSTIC CENTERS
9.3 CUSTOM LAB SERVICE PROVIDERS
9.4 ACADEMIC & RESEARCH INSTITUTES
10 MICROBIOLOGY TESTING/CLINICAL MICROBIOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2014–2018)
11.3.2 KEY AGREEMENT, PARTNERSHIPS, AND COLLABORATIONS (2014–2018)
11.3.3 KEY ACQUISITIONS AND DIVESTMENTS (2014-2018)
11.3.4 KEY EXPANSIONS (2014-2018)
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BIOM?RIEUX
12.2 DANAHER CORPORATION
12.3 BECTON, DICKINSON AND COMPANY
12.4 ABBOTT
12.5 ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
12.6 BRUKER
12.7 HOLOGIC
12.8 BIO-RAD
12.9 QIAGEN
12.10 THERMO FISHER SCIENTIFIC
12.11 AGILENT
12.12 MERCK KGAA
12.13 SHIMADZU
12.14 3M
12.15 NEOGEN
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY AND PRICING
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 OPPORTUNITY INDICATORS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Burden of infectious diseases
2.2.2.2 Healthcare expenditure patterns
2.2.2.3 Rapid growth in geriatric population
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 The number of new products launched as clinical microbiology products
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH LIMITATIONS AND ASSUMPTIONS
2.5.1 LIMITATIONS
2.5.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MICROBIOLOGY TESTING MARKET (2018-2023)
4.2 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018-2023 (USD BILLION)
4.3 CLINICAL MICROBIOLOGY MARKET (2018-2023)
4.4 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
4.5 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2018 VS. 2023 (USD MILLION)
4.6 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in disease diagnostics
5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics
5.2.1.3 Increased funding and public-private investments
5.2.2 RESTRAINTS
5.2.2.1 Limited reimbursement policies for microbiology testing procedures
5.2.2.2 Unfavorable regulatory scenario
5.2.3 OPPORTUNITIES
5.2.3.1 Improving healthcare infrastructure across emerging countries
5.2.4 CHALLENGES
5.2.4.1 Operational barriers related to the use of diagnostic tests
5.2.4.2 Bundled sales of microbiology testing products - A key challenge for small and emerging reagent manufacturers
6 MICROBIOLOGY TESTING MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 PHARMACEUTICAL APPLICATIONS
6.3 CLINICAL APPLICATIONS
6.4 FOOD TESTING APPLICATIONS
6.5 ENERGY APPLICATIONS
6.6 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS
6.7 ENVIRONMENTAL APPLICATIONS
7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 INSTRUMENTS
7.2.1 LABORATORY INSTRUMENTS
7.2.1.1 Incubators
7.2.1.2 Gram stainers
7.2.1.3 Bacterial colony counters
7.2.1.4 Autoclave sterilizers
7.2.1.5 Microbial air samplers
7.2.1.6 Anaerobic culture systems
7.2.1.7 Petri dish fillers
7.2.1.8 Blood culture systems
7.2.1.9 Microbial culture systems
7.2.1.10 Other laboratory instruments
7.2.2 MICROBIOLOGY ANALYZERS
7.2.2.1 Molecular diagnostic instruments
7.2.2.2 Microscopes
7.2.2.3 Mass spectrometers
7.3 REAGENTS
7.3.1 PATHOGEN-SPECIFIC KITS
7.3.2 GENERAL REAGENTS
8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA
8.1 INTRODUCTION
8.2 RESPIRATORY DISEASES
8.3 BLOODSTREAM INFECTIONS
8.4 GASTROINTESTINAL DISEASES
8.5 SEXUALLY TRANSMITTED DISEASES
8.6 URINARY TRACT INFECTIONS
8.7 PERIODONTAL DISEASES
8.8 OTHER DISEASES
9 CLINICAL MICROBIOLOGY MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & DIAGNOSTIC CENTERS
9.3 CUSTOM LAB SERVICE PROVIDERS
9.4 ACADEMIC & RESEARCH INSTITUTES
10 MICROBIOLOGY TESTING/CLINICAL MICROBIOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2014–2018)
11.3.2 KEY AGREEMENT, PARTNERSHIPS, AND COLLABORATIONS (2014–2018)
11.3.3 KEY ACQUISITIONS AND DIVESTMENTS (2014-2018)
11.3.4 KEY EXPANSIONS (2014-2018)
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BIOM?RIEUX
12.2 DANAHER CORPORATION
12.3 BECTON, DICKINSON AND COMPANY
12.4 ABBOTT
12.5 ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
12.6 BRUKER
12.7 HOLOGIC
12.8 BIO-RAD
12.9 QIAGEN
12.10 THERMO FISHER SCIENTIFIC
12.11 AGILENT
12.12 MERCK KGAA
12.13 SHIMADZU
12.14 3M
12.15 NEOGEN
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 2 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 3 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 5 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 6 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 7 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 8 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
Table 9 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 11 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 12 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 13 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 14 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 15 CLINICAL MICROBIOLOGY INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 16 CLINICAL MICROBIOLOGY GRAM STAINERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 17 CLINICAL MICROBIOLOGY BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 18 CLINICAL MICROBIOLOGY AUTOCLAVE STERILIZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 19 CLINICAL MICROBIOLOGY MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 20 CLINICAL MICROBIOLOGY ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 21 CLINICAL MICROBIOLOGY PETRI DISH FILLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 22 CLINICAL MICROBIOLOGY BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 23 CLINICAL MICROBIOLOGY MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 24 CLINICAL MICROBIOLOGY OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 25 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 26 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 27 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 28 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 29 CLINICAL MICROBIOLOGY MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 30 CLINICAL MICROBIOLOGY MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 31 CLINICAL MICROBIOLOGY MASS SPECTROMETERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 32 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 33 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 34 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 35 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 36 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 37 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 38 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 39 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 40 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 41 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 42 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2016–2023 (USD MILLION)
Table 43 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 44 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 45 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2016–2023 (USD MILLION)
Table 46 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 47 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 48 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 49 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 50 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2016–2023 (USD MILLION)
Table 51 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 52 MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 54 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 58 NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 62 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 63 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 67 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 EUROPE: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 70 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 71 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 76 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 78 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 79 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 82 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 85 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 87 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 88 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 89 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 90 APAC: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 91 APAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 92 APAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 APAC: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 APAC: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 95 APAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 96 APAC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 97 APAC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 98 APAC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 99 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 100 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 101 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 103 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 105 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 106 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 107 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 109 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 110 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 ROW: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 112 ROW: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 113 ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 114 ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 115 ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 116 ROW: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 ROW: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 118 ROW: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 119 ROW: CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 120 LATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 121 LATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 LATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 123 MEA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 124 MEA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 125 MEA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 1 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 2 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 3 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 5 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 6 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 7 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 8 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
Table 9 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 11 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 12 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 13 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 14 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 15 CLINICAL MICROBIOLOGY INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 16 CLINICAL MICROBIOLOGY GRAM STAINERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 17 CLINICAL MICROBIOLOGY BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 18 CLINICAL MICROBIOLOGY AUTOCLAVE STERILIZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 19 CLINICAL MICROBIOLOGY MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 20 CLINICAL MICROBIOLOGY ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 21 CLINICAL MICROBIOLOGY PETRI DISH FILLERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 22 CLINICAL MICROBIOLOGY BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 23 CLINICAL MICROBIOLOGY MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 24 CLINICAL MICROBIOLOGY OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 25 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 26 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 27 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 28 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 29 CLINICAL MICROBIOLOGY MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 30 CLINICAL MICROBIOLOGY MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 31 CLINICAL MICROBIOLOGY MASS SPECTROMETERS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 32 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 33 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 34 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 35 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 36 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 37 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 38 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY DISEASE AREA, 2016-2023 (USD MILLION)
Table 39 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
Table 40 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 41 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 42 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2016–2023 (USD MILLION)
Table 43 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 44 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 45 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2016–2023 (USD MILLION)
Table 46 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 47 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 48 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 49 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 50 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2016–2023 (USD MILLION)
Table 51 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 52 MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 54 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 58 NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 62 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 63 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 67 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 EUROPE: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 70 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 71 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 76 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 78 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 79 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 82 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 85 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 87 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 88 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 89 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 90 APAC: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 91 APAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 92 APAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 APAC: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 APAC: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 95 APAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 96 APAC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 97 APAC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 98 APAC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 99 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 100 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 101 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 103 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 105 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 106 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 107 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 109 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 110 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 ROW: MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 112 ROW: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 113 ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 114 ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 115 ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 116 ROW: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 ROW: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION)
Table 118 ROW: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 119 ROW: CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 120 LATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 121 LATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 LATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 123 MEA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 124 MEA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 125 MEA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 SOUTH AFRICA AND INDIA HAD THE LARGEST HIV-AIDS PATIENT POPULATION DURING 2010–2016
Figure 3 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2005–2015
Figure 4 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2005–2015
Figure 5 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011–2030)
Figure 6 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980–2010 VS. 2010–2040)
Figure 7 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION, BY COUNTRY (2011–2030)
Figure 8 THE NUMBER OF NEW PRODUCTS LAUNCHED IN THE CLINICAL MICROBIOLOGY MARKET (2014–2017)
Figure 9 BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET
Figure 10 TOP-DOWN APPROACH: MICROBIOLOGY TESTING MARKET
Figure 11 DATA TRIANGULATION
Figure 12 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 13 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
Figure 14 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA (2018 VS. 2023)
Figure 15 CLINICAL MICROBIOLOGY MARKET SHARE, BY REGION (2018)
Figure 16 INCREASING GLOBAL BURDEN OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE MICROBIOLOGY TESTING INDUSTRY
Figure 17 PHARMACEUTICAL APPLICATIONS ARE EXPECTED TO DOMINATE THE MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
Figure 18 INCREASED FUNDING AND PUBLIC-PRIVATE INVESTMENT ARE KEY FACTORS DRIVING MARKET GROWTH
Figure 19 NORTH AMERICA IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
Figure 20 RESPIRATORY DISEASES ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD
Figure 21 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKETS ACROSS ALL REGIONS UNTIL 2023
Figure 23 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE— DEVELOPED VS. DEVELOPING COUNTRIES (2005–2015)
Figure 24 FOOD TESTING APPLICATIONS TO REGISTER THE HIGHEST GROWTH RATE IN THE GLOBAL MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
Figure 25 LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET UNTIL 2023
Figure 26 INCUBATORS TO DOMINATE THE CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
Figure 27 MOLECULAR DIAGNOSTIC INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY ANALYZERS MARKET UNTIL 2023
Figure 28 PATHOGEN-SPECIFIC KITS ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY REAGENTS MARKET
Figure 29 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 30 CUSTOM LAB SERVICE PROVIDERS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 32 EUROPE: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 33 APAC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 34 ROW: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 35 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, 2014–2017
Figure 36 GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2017
Figure 37 BIOM?RIEUX: COMPANY SNAPSHOT
Figure 38 DANAHER: COMPANY SNAPSHOT
Figure 39 BD: COMPANY SNAPSHOT
Figure 40 ABBOTT: COMPANY SNAPSHOT
Figure 41 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
Figure 42 BRUKER: COMPANY SNAPSHOT
Figure 43 HOLOGIC: COMPANY SNAPSHOT
Figure 44 BIO-RAD: COMPANY SNAPSHOT
Figure 45 QIAGEN: COMPANY SNAPSHOT
Figure 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
Figure 47 AGILENT: COMPANY SNAPSHOT
Figure 48 MERCK KGAA: COMPANY SNAPSHOT
Figure 49 SHIMADZU: COMPANY SNAPSHOT
Figure 50 3M: COMPANY SNAPSHOT
Figure 51 NEOGEN: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 SOUTH AFRICA AND INDIA HAD THE LARGEST HIV-AIDS PATIENT POPULATION DURING 2010–2016
Figure 3 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2005–2015
Figure 4 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2005–2015
Figure 5 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011–2030)
Figure 6 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980–2010 VS. 2010–2040)
Figure 7 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION, BY COUNTRY (2011–2030)
Figure 8 THE NUMBER OF NEW PRODUCTS LAUNCHED IN THE CLINICAL MICROBIOLOGY MARKET (2014–2017)
Figure 9 BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET
Figure 10 TOP-DOWN APPROACH: MICROBIOLOGY TESTING MARKET
Figure 11 DATA TRIANGULATION
Figure 12 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 13 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018)
Figure 14 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA (2018 VS. 2023)
Figure 15 CLINICAL MICROBIOLOGY MARKET SHARE, BY REGION (2018)
Figure 16 INCREASING GLOBAL BURDEN OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE MICROBIOLOGY TESTING INDUSTRY
Figure 17 PHARMACEUTICAL APPLICATIONS ARE EXPECTED TO DOMINATE THE MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
Figure 18 INCREASED FUNDING AND PUBLIC-PRIVATE INVESTMENT ARE KEY FACTORS DRIVING MARKET GROWTH
Figure 19 NORTH AMERICA IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
Figure 20 RESPIRATORY DISEASES ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD
Figure 21 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKETS ACROSS ALL REGIONS UNTIL 2023
Figure 23 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE— DEVELOPED VS. DEVELOPING COUNTRIES (2005–2015)
Figure 24 FOOD TESTING APPLICATIONS TO REGISTER THE HIGHEST GROWTH RATE IN THE GLOBAL MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
Figure 25 LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET UNTIL 2023
Figure 26 INCUBATORS TO DOMINATE THE CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
Figure 27 MOLECULAR DIAGNOSTIC INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY ANALYZERS MARKET UNTIL 2023
Figure 28 PATHOGEN-SPECIFIC KITS ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY REAGENTS MARKET
Figure 29 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 30 CUSTOM LAB SERVICE PROVIDERS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 32 EUROPE: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 33 APAC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 34 ROW: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
Figure 35 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, 2014–2017
Figure 36 GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2017
Figure 37 BIOM?RIEUX: COMPANY SNAPSHOT
Figure 38 DANAHER: COMPANY SNAPSHOT
Figure 39 BD: COMPANY SNAPSHOT
Figure 40 ABBOTT: COMPANY SNAPSHOT
Figure 41 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
Figure 42 BRUKER: COMPANY SNAPSHOT
Figure 43 HOLOGIC: COMPANY SNAPSHOT
Figure 44 BIO-RAD: COMPANY SNAPSHOT
Figure 45 QIAGEN: COMPANY SNAPSHOT
Figure 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
Figure 47 AGILENT: COMPANY SNAPSHOT
Figure 48 MERCK KGAA: COMPANY SNAPSHOT
Figure 49 SHIMADZU: COMPANY SNAPSHOT
Figure 50 3M: COMPANY SNAPSHOT
Figure 51 NEOGEN: COMPANY SNAPSHOT
